Literature DB >> 23625944

Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey.

Jesper Hastrup Svendsen1, Nikolaos Dagres, Dan Dobreanu, Maria Grazia Bongiorni, Germanas Marinskis, Carina Blomström-Lundqvist.   

Abstract

The aims of this survey was to provide insight into treatment activity, the strategy of treatment, and risk stratification of patients with asymptomatic and symptomatic ventricular pre-excitation across Europe. Fifty-eight centres, members of the European Heart Rhythm Association EP research network, covering 20 countries answered the survey questions. All centres were high-volume ablation centres. A younger person with asymptomatic Wolff-Parkinson-White (WPW) pattern has a higher likelihood of being risk-stratified or receiving ablation therapy compared with an older subject. Two-thirds of centres report that they have observed a decline in the number of patients ablated for an accessory pathway during the last 10 years. Pre-excited atrial fibrillation is rarely seen. Discontinuation of a scheduled WPW ablation due to close vicinity of the accessory pathway to the AV node happens very rarely. Patients with a first episode of pre-excited atrial fibrillation would immediately be referred for catheter ablation to be performed within weeks by 80.4% of the centres. A significant proportion of responders (50.9%) would use electrical cardioversion to restore sinus rhythm in a patient with pre-excited atrial fibrillation. With respect to the choice of antiarrhythmic medication for a patient with pre-excited AF, the majority (80.0%) would choose class 1C antiarrhytmic drugs while waiting for a catheter ablation. A patient seen in the emergency room with a second episode of orthodromic atrioventricular reentry tachycardia would be referred for immediate ablation by 79.2-90.6% of centres depending on the presence of pre-excitation. The volume of paediatric ablations performed on children younger than 12 years was low (46.4%: 0 patients per year; 46.4%: 1-9 patients per year). The majority of responding centres (61-69%) report that their country lack national guidelines dealing with clinical strategies related to WPW. There is a need for national guidelines dealing with clinical strategy in patients with WPW syndrome. Older individuals with asymptomatic WPW pattern have a higher risk of not receiving risk stratification or curative therapy with ablation compared with younger patients, despite the higher risk of developing atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625944     DOI: 10.1093/europace/eut094

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

Review 1.  [AV-reentrant tachycardia and Wolff-Parkinson-White syndrome : Diagnosis and treatment].

Authors:  Frederik Voss; Lars Eckardt; Sonia Busch; Heidi L Estner; Daniel Steven; Philipp Sommer; Christian von Bary; Hans-Ruprecht Neuberger
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-11-22

Review 2.  Management of Asymptomatic Wolff-Parkinson-White Pattern in Young Patients: Has Anything Changed?

Authors:  Daniela Raposo; Natália António; Helena Andrade; Pedro Sousa; António Pires; Lino Gonçalves
Journal:  Pediatr Cardiol       Date:  2019-05-08       Impact factor: 1.655

3.  Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways.

Authors:  Mu Chen; Xiangfei Feng; Jian Sun; Qunshan Wang; Pengpai Zhang; Jun Wang; Yi-Gang Li
Journal:  Int J Cardiol Heart Vasc       Date:  2015-02-28

Review 4.  Review paper on WPW and athletes: Let sleeping dogs lie?

Authors:  Lisa W M Leung; Mark M Gallagher
Journal:  Clin Cardiol       Date:  2020-06-27       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.